Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

  1. Lipton, A.
  2. Fizazi, K.
  3. Stopeck, A.T.
  4. Henry, D.H.
  5. Smith, M.R.
  6. Shore, N.
  7. Martin, M.
  8. Vadhan-Raj, S.
  9. Brown, J.E.
  10. Richardson, G.E.
  11. Saad, F.
  12. Yardley, D.A.
  13. Zhou, K.
  14. Balakumaran, A.
  15. Braun, A.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2016

Alea: 53

Orrialdeak: 75-83

Mota: Artikulua

DOI: 10.1016/J.EJCA.2015.09.011 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus